Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP)
Stock · NASDAQ · Health Care
$18.61as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$13.29
Industry
Biotechnology: Pharmaceutical Preparations
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Competitors
Chosen by industry and closest market cap.
- FBIOPFortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock$18.61▲ 0.27%Market cap $630.50MP/E —
- BBOTBridgeBio Oncology Therapeutics Inc. Common Stock$8.74▼ 4.79%Market cap $660.88MP/E —$7$14.87
- CRMDCorMedix Inc. Common Stock$8.31▼ 0.06%Market cap $592.31MP/E 3.53$6.13$14.96
- CLYMClimb Bio Inc. Common Stock$14.56▼ 3.32%Market cap $676.28MP/E —$1.54$18.33
- OCSOculis Holding AG Ordinary shares$12.21▼ 1.77%Market cap $689.43MP/E —$10.52$34.48
- CTMXCytomX Therapeutics Inc. Common Stock$3.22▼ 5.99%Market cap $690.12MP/E —$1.9$8.21
- MPLTMapLight Therapeutics Inc. Common Stock$12.64▲ 0.80%Market cap $569.09MP/E —$9.1$40.43
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FBIOP Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | $630.50M | — | $18.61 | ▲ 0.27% | |
| BBOT BridgeBio Oncology Therapeutics Inc. Common Stock | $660.88M | — | $8.74 | ▼ 4.79% | $7$14.87 |
| CRMD CorMedix Inc. Common Stock | $592.31M | 3.53 | $8.31 | ▼ 0.06% | $6.13$14.96 |
| CLYM Climb Bio Inc. Common Stock | $676.28M | — | $14.56 | ▼ 3.32% | $1.54$18.33 |
| OCS Oculis Holding AG Ordinary shares | $689.43M | — | $12.21 | ▼ 1.77% | $10.52$34.48 |
| CTMX CytomX Therapeutics Inc. Common Stock | $690.12M | — | $3.22 | ▼ 5.99% | $1.9$8.21 |
| MPLT MapLight Therapeutics Inc. Common Stock | $569.09M | — | $12.64 | ▲ 0.80% | $9.1$40.43 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.